Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors

Gastrointestinal stromal tumors (GIST) are rare and mesenchymal in origin with a yearly incidence of 10‐15 cases per million people. If it is technically resectable, surgical resection is the mainstay of therapy regardless of tumor location,. Although complete (R0) resection can be achieved in up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwatsuki, Masaaki, Harada, Kazuto, Iwagami, Shiro, Eto, Kojiro, Ishimoto, Takatsugu, Baba, Yoshifumi, Yoshida, Naoya, Ajani, Jaffer A., Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345649/
https://www.ncbi.nlm.nih.gov/pubmed/30697609
http://dx.doi.org/10.1002/ags3.12211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345649/
https://www.ncbi.nlm.nih.gov/pubmed/30697609
http://dx.doi.org/10.1002/ags3.12211

Ejemplares similares